Gloria Omosa-Manyonyi

Safety and Immunogenicity Study of Multiclade HIV-1 Adenoviral Vector Vaccine Alone or as Boost following a Multiclade HIV-1 DNA Vaccine in Africa

Walter Jaoko, Etienne Karita, Kayitesi Kayitenkore et al. · PLoS ONE · 2010 · 118 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Studies of a prophylactic HIV-1 vaccine candidate based on modified vaccinia virus Ankara (MVA) with and without DNA priming: Effects of dosage and route on safety and immunogenicity

Barry Peters, Walter Jaoko, Eftyhia Vardas et al. · Vaccine · 2006 · 109 citations

Veterinary Medicine, Immunology, Infectious Diseases +16

Prevalence and Factors Associated with Contraceptive Use Among Kenyan Women Aged 15–49 Years

Laura Lusike Lunani, Andrew Abaasa, Gloria Omosa-Manyonyi · AIDS and Behavior · 2018 · 37 citations · Full text

Medicine, Gynecology, Obstetrics +16

A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of an Adjuvanted HIV-1 Gag-Pol-Nef Fusion Protein and Adenovirus 35 Gag-RT-Int-Nef Vaccine in Healthy HIV-Uninfected African Adults

Gloria Omosa-Manyonyi, Juliet Mpendo, Eugene Ruzagira et al. · PLoS ONE · 2015 · 34 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

First-in-Human Evaluation of the Safety and Immunogenicity of an Intranasally Administered Replication-Competent Sendai Virus–Vectored HIV Type 1 Gag Vaccine: Induction of Potent T-Cell or Antibody Responses in Prime-Boost Regimens

Julien Nyombayire, Omu Anzala, Brian Gazzard et al. · The Journal of Infectious Diseases · 2016 · 33 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17